- Report
- September 2024
- 296 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 193 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 140 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- May 2024
- 138 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- March 2025
- 78 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 271 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 289 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 178 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more